The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
Abstract
Background— Allopurinol has been shown to improve endothelial function in chronic heart failure. This study aimed to establish its mechanism of action and to construct a dose–response curve for the effect of allopurinol. Methods and Results— Two randomized, placebo-controlled, double-blind, crossover studies were performed for 1 month on patients with New York Heart Association Class II–III chronic heart failure, comparing 300 mg allopurinol, 600 mg allopurinol, and placebo for the first study and 1000 mg probenecid versus placebo in the second study. Endothelial function was assessed by standard forearm venous occlusion plethysmography. Allopurinol 600 mg/d significantly increased forearm blood flow response to acetylcholine compared with both allopurinol 300 mg/d and placebo (% change in forearm blood flow [mean±SEM]: 240.31±38.19% versus 152.10±18.21% versus 73.96±10.29%, P <0.001). For similar levels of urate lowering, the uricosuric agent probenecid had no effect on endothelial function. Sodium nitroprusside response was unchanged by all treatments. Vitamin C and acetylcholine coinfusion data showed that 600 mg/d allopurinol completely abolished the oxidative stress that was sensitive to high-dose vitamin C. Conclusions— For the first time, we have shown that a steep dose–response relationship exists between allopurinol and its effect on endothelial function. We also showed that the mechanism of improvement in endothelial function with allopurinol lies in its ability to reduce vascular oxidative stress and not in urate reduction. The reduction in vascular oxidative stress was profound because high-dose allopurinol totally abolished the oxidative stress that was sensitive to the high-dose vitamin C that was used in this study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
The measurement of volume changes in human limbs
Whitney, R. J. (1953) · The Journal of Physiology · doi:10.1113/jphysiol.1953.sp004926 · Cited by 1,489
Taddei, S., Virdis, A., Ghiadoni, L., Magagna, A., & Salvetti, A. (1998) · Circulation · doi:10.1161/01.cir.97.22.2222 · Cited by 762
Anker, S. D., Doehner, W., Rauchhaus, M., Sharma, R., Francis, D., Knosalla, C., Davos, C. H., Cicoira, M., Shamim, W., Kemp, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065637.10517.a0 · Cited by 593
Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Verdecchia, P., Schillaci, G., Reboldi, G., Santeusanio, F., Porcellati, C., & Brunetti, P. (2000) · Hypertension · doi:10.1161/01.hyp.36.6.1072 · Cited by 558
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504
Self-citationAllopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Butler, R., Morris, A. D., Belch, J. J. F., Hill, A., & Struthers, A. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.746 · Cited by 463
Self-citationAllopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy
Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., & Hare, J. M. (2001) · Circulation · doi:10.1161/hc4501.098928 · Cited by 436
Regoli, F., & Winston, G. W. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8637 · Cited by 403
Measuring Forearm Blood Flow and Interpreting the Responses to Drugs and Mediators
Benjamin, N., Calver, A., Collier, J., Robinson, B., Vallance, P., & Webb, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.918 · Cited by 399
Ting, H. H., Timimi, F. K., Haley, E. A., Roddy, M.-A., Ganz, P., & Creager, M. A. (1997) · Circulation · doi:10.1161/01.cir.95.12.2617 · Cited by 355
Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications
Wilkinson, I. B., & Webb, D. J. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01495.x · Cited by 355
Weir, C. J., Muir, S. W., Walters, M. R., & Lees, K. R. (2003) · Stroke · doi:10.1161/01.str.0000081983.34771.d2 · Cited by 334
Xanthine Oxidase Inhibition Reverses Endothelial Dysfunction in Heavy Smokers
Guthikonda, S., Sinkey, C., Barenz, T., & Haynes, W. G. (2003) · Circulation · doi:10.1161/01.cir.0000046448.26751.58 · Cited by 225
Systemic Endothelial Dysfunction as an Early Predictor of Adverse Outcome in Heart Failure
Heitzer, T. A., Baldus, S. E., Kodolitsch, Y. V., Rudolph, V., & Meinertz, T. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166516.52477.81 · Cited by 161
Sherman, D. L., Keaney, J. F., Biegelsen, E. S., Duffy, S. J., Coffman, J. D., & Vita, J. A. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.936 · Cited by 158
Struthers, A. D., Donnan, P. T., Lindsay, P., McNaughton, D., Broomhall, J., & MacDonald, T. M. (2002) · Heart · doi:10.1136/heart.87.3.229 · Cited by 147
Self-citationJohn, S., Schneider, M. P., Delles, C., Jacobi, J., & Schmieder, R. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.06.027 · Cited by 145
How reproducible is bilateral forearm plethysmography?
Petrie, J. R., Ueda, S., Morris, A. D., Murray, L. S., Elliott, H. L., & Connell, J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00656.x · Cited by 110
Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects
Turnheim, Krivanek, & Oberbauer (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00041.x · Cited by 109
Endothelial dysfunction: clinical strategies for treating oxidant stress
Fenster, B. E., Tsao, P. S., & Rockson, S. G. (2003) · American Heart Journal · doi:10.1016/s0002-8703(02)94796-4 · Cited by 96
Mellin, V., Isabelle, M., Oudot, A., Vergely, C., Monteil, C., Meglio, B. D., Henry, J., Dautréaux, B., Rochette, L., Thuillez, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi305 · Cited by 91
Watanabe, S., Tagawa, T., Yamakawa, K., Shimabukuro, M., & Ueda, S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000187465.55507.85 · Cited by 82
Hyperuricaemia does not impair cardiovascular function in healthy adults
Waring, W. S., Adwani, S. H., Breukels, O., Webb, D. J., & Maxwell, S. R. J. (2004) · Heart · doi:10.1136/hrt.2003.016121 · Cited by 80
Cross, J. M., Donald, A. E., Nuttall, S. L., Deanfield, J. E., Woolfson, R. G., & MacAllister, R. J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00852.x · Cited by 71
Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration
Teng, R., Ye, Y.-Z. U., Parks, D. A., & Beckman, J. S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01020-1 · Cited by 69
Böhm, F., Settergren, M., & Pernow, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.018 · Cited by 66
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects
GRAHAM, S., Day, R. O., WONG, H., McLachlan, A. J., Bergendal, L., Miners, J. O., & Birkett, D. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.03116.x · Cited by 58
Tetrahydrobiopterin correctsEscherichia coliendotoxin-induced endothelial dysfunction
Mittermayer, F., Pleiner, J., Schaller, G., Zorn, S., Namiranian, K., Kapiotis, S., Bond, G., Wolfrum, M., Brügel, M., Thiery, J., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00057.2005 · Cited by 42
Bridges, A., SCOTT, N. A., McNeill, G. P., et al. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060116 · Cited by 42
Hirooka, Y., Eshima, K., Setoguchi, S., Kishi, T., Egashira, K., & Takeshita, A. (2003) · Hypertension Research · doi:10.1291/hypres.26.953 · Cited by 35
Human forearm venous occlusion plethysmography: methodology, presentation and analysis
Chin-Dusting, J. P. F., Cameron, J. D., Dart, A. M., & Jennings, G. (1999) · Clinical Science · doi:10.1042/cs19990033 · Cited by 25
Comparison of two plethysmography systems in assessment of forearm blood flow
Leslie, S. J., Attinà, T. M., Hultsch, E., Bolscher, L., Grossman, M., Denvir, M. A., & Webb, D. J. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00567.2002 · Cited by 23
Effect of systemic vitamin C on free fatty acid-induced lipid peroxidation
Bayerle‐Eder, M., Pleiner, J., Mittermayer, F., Schaller, G., Roden, M., Waldhäusl, W., Bieglmayer, C., & Wolzt, M. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70140-4 · Cited by 22
Forearm plethysmography: does the right arm know what the left is doing?
Petrie, J. R., Perry, C. G., Cleland, S. J., Murray, L. S., Elliott, H. L., & Connell, J. (2000) · Clinical Science · doi:10.1042/cs0980209 · Cited by 14
Cited by
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Feig, D. I., Soletsky, B., & Johnson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.924 · Cited by 914
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Reactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769
Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
Johnson, R. J., Nakagawa, T., Sanchez-Lozada, L. G., Shafiu, M., Sundaram, S., Le, M., Ishimoto, T., Sautin, Y. Y., & Lanaspa, M. A. (2013) · Diabetes · doi:10.2337/db12-1814 · Cited by 760
Metadata
- Authors
- George, J., Carr, E., Davies, J., Belch, J. J. F., & Struthers, A.
- Venue
- Circulation
- Published
- 2006-12-05
- Volume
- 114
- Issue
- 23
- Pages
- 2508-2516
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2147978034
- Cited by
- 569
- References
- 36
- FWCI
- 15.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.